Rallybio Corporation (RLYB) Misses Q4 EPS by 3c

Rallybio Corporation (NASDAQ: RLYB) reported Q4 EPS of ($0.50), $0.03 worse than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Rallybio Corporation (RLYB) click here.

You May Also Be Interested In

• John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
• Victoria’s Secret shares slump 16% on weak Q3 operating income outlook
• Lands' End (LE) Tops Q2 EPS by 1c